Malin Corporation PLC (MLC)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell
€8.00
Buy
€9.80
€0.00 (+0.00%)
Malin Corporation PLC is a global life sciences company. The firm's investee companies are in science and discovery, clinical and commercial sectors.
Prices updated at 30 May 2025, 16:30 BST
| Prices minimum 15 mins delay
|
Prices in EUR
0.17%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Liam Daniel
CEO
-
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
3
Head office
50 Richmond Street South
Dublin
Ireland
D02 FK02
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Christopher Pedrick Non-Executive Director | - | - | - | - | - |
Dr. Jean-Michel Cossery Non-Executive Independent Director | - | - | - | - | - |
Dr. Kirsten Drejer Non-Executive Independent Director | - | - | - | - | - |
Fiona Dunlevy Executive Director and Company Secretary | - | - | - | - | - |
Liam Daniel Non-Executive Chairman of the Board | - | - | - | - | - |
Rudy Mareel Non-Executive Lead Independent Director | - | - | - | - | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| No data | ||||||
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| No data | |||||||
Please note that past performance is not a reliable indicator of future returns.
